MERRIMACK PHARMACEUTICALS INC (MACK) Financial Statements

MERRIMACK PHARMACEUTICALS INC (MACK) files with the U.S. Securities and Exchange Commission under CIK 0001274792. 10KGenie shows its annual and quarterly statements from SEC filings.

Key Figures, Fiscal Year 2023

Total Assets: $19.19 million
Net Cash from Operations: -$1.52 million

Fiscal year ended Dec 31, 2023. Latest periodic SEC filing: May 15, 2024. Source: SEC filings (EDGAR XBRL).

Open the full financial statements for MACK in 10KGenie

Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History